Luck et al., 1990 - Google Patents
Recombinant methionyl bovine prolactin: loss of bioactivity after single amino acid deletions from putative helical regionsLuck et al., 1990
View PDF- Document ID
- 14877503538586962276
- Author
- Luck D
- Gout P
- Kelsay K
- Atkinson T
- Beer C
- Smith M
- Publication year
- Publication venue
- Molecular Endocrinology
External Links
Snippet
We have previously described a method for producing recombinant methionyl bovine PRL (Met-bPRL), which is as bioactive as the authentic hormone in the Nb2 cell lactogen bioassay; in contrast, a MetbPRL variant lacking tyrosine 28 was essentially devoid of …
- 150000001413 amino acids 0 title abstract description 43
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormones [GH] (Somatotropin)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/746—Erythropoetin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cunningham et al. | Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule | |
Pavlakis et al. | Expression of two human growth hormone genes in monkey cells infected by simian virus 40 recombinants. | |
Niall et al. | Sequences of pituitary and placental lactogenic and growth hormones: evolution from a primordial peptide by gene reduplication | |
Shepard et al. | A single amino acid change in IFN-β 1 abolishes its antiviral activity | |
Goffin et al. | Alanine-scanning mutagenesis of human prolactin: importance of the 58-74 region for bioactivity. | |
WO1996004307A1 (en) | Aspb1 insulin analogs | |
Fine et al. | Recombinant carp (Cyprinus carpio) growth hormone: expression, purification, and determination of biological activity in vitro and in vivo | |
Chen et al. | Amino acid residues in the third alpha-helix of growth hormone involved in growth promoting activity. | |
EP0790305B1 (en) | Mutant human growth hormones and their uses | |
Luck et al. | Recombinant methionyl bovine prolactin: loss of bioactivity after single amino acid deletions from putative helical regions | |
CA1340122C (en) | Modifications of somatotropins for enhanced stability | |
Chen et al. | Conversion of bovine growth hormone cysteine residues to serine affects secretion by cultured cells and growth rates in transgenic mice. | |
Luck et al. | Single amino acid substitutions in recombinant bovine prolactin that markedly reduce its mitogenic activity in Nb2 cell cultures | |
Anaguchi et al. | Ligand binding characteristics of the carboxyl-terminal domain of the cytokine receptor homologous region of the granulocyte colony-stimulating factor receptor | |
Bernichtein et al. | The N-terminus of human prolactin modulates its biological properties | |
Luck et al. | Analysis of disuiphide bridge function in recombinant bovine prolactin using site-specific mutagenesis and renaturation under mild alkaline conditions: a crucial role for the central disuiphide bridge in the mitogenic activity of the hormone | |
EP1325930A1 (en) | Mammal prolactin variants | |
BRPI0706628A2 (en) | fsh d3n glycosylation variant | |
US20010036662A1 (en) | Prolactin antagonists and uses thereof | |
Arbatti et al. | β2‐Inhibin contains the active core of human seminal plasma β‐inhibin: synthesis and bioactivity | |
Merli et al. | An expression system for the single-step production of recombinant human amidated calcitonin | |
US5130422A (en) | Variant somatotropin-encoding DNA | |
Davis et al. | Mutational analysis of a lactogenic hormone reveals a role for lactogen-specific amino acid residues in receptor binding and mitogenic activity | |
KR20010023749A (en) | Expression of gonadotropins in dictyostelium | |
Vashdi-Elberg et al. | N-terminal-truncated recombinant analogs of bovine placental lactogen: interaction with human and rat growth hormone receptors and insulin-like growth factor-I secretion mediated by somatogenic receptors in rat hepatocytes |